Drug intelligence / Profile preview

Xiaoshilidan Capsules

Development stage: Unknown
Lead developer: Buchang Pharmaceuticals
Administration: Oral

Overview

Xiaoshilidan Capsules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is primarily indicated for the treatment of gallstones (cholelithiasis) and cholecystitis. The formulation is designed to clear heat, promote dampness removal, and facilitate the expulsion of stones from the biliary system by improving gallbladder function. It is widely used in China for digestive diseases related to the gallbladder and bile ducts.

Brand names: Xiaoshilidan Capsules
Other names: 消石利胆胶囊Xiaoshi Lidan Jiaonang

Beyond the preview

Go deeper on Xiaoshilidan Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoshilidan Capsules.

Explore the full profile